Protecting CCI And Partnership Submissions For EMA’s Clinical Data Publication Policy

A senior Janssen official explains how companies should prepare documents to ensure information that they believe is commercially confidential is protected under the European Medicines Agency’s clinical data publication policy and looks to some of the challenges they may face when it comes to drugs developed in a partnership.